Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications: Table 1
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Randomised allocation of vaccine or placebo is the preferred method to assess the effects of the vaccine on clinical outcomes relevant to the individual patient. In the absence of phase 3 trials using clinical end points, notably post-influenza complications, alternative non-experimental designs to evaluate vaccine effects or safety are often used. The application of these designs may, however, lead to invalid estimates of vaccine effectiveness or safety. As patients with poor prognosis are more likely to be immunised, selection for vaccination is confounded by patient factors that are also related to clinical end points. This paper describes several design and analytical methods aimed at limiting or preventing this confounding by indication in non-experimental studies. In short, comparison of study groups with similar prognosis, restriction of the study population, and statistical adjustment for dissimilarities in prognosis are important tools and should be considered. Only if the investigator is able to show that confounding by indication is sufficiently controlled for, results of a non-experimental study may be of use to direct an evidence based vaccine policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Clinical effectiveness of influenza vaccination in Manitoba.
Fedson, D. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160074032 · Cited by 278
Cited by
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 656
Self-citationSkowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R., Sethi, P., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000258 · Cited by 297
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
Lang, P.-O., Mendes, Socquet, Assir, Govind, & Aspinall (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s25215 · Cited by 245
Skowronski, D. M., Masaro, C., Kwindt, T. L., Mak, A., Petric, M., Li, Y., Sebastian, R., Chong, M., Tam, T., & De Serres, G. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.10.002 · Cited by 202
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Metadata
- Authors
- Hak, E., Verheij, T. J. M., Grobbee, D. E., Nichol, K. L., & Hoes, A. W.
- Venue
- Journal of Epidemiology and Community Health
- Publisher
- BMJ
- Published
- 2002-12
- Volume
- 56
- Issue
- 12
- Pages
- 951-955
- ISSN
- 0141-7681 (ISSN-L)
- 0143-005X
- 1470-2738
- OpenAlex
- W2098380460
- Cited by
- 138
- References
- 5
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications: Table 1. https://app.cochat.ai/papers/10.1136/jech.56.12.951
- The paper
- Hak, E., Verheij, T. J. M., Grobbee, D. E., Nichol, K. L., & Hoes, A. W. (2002). Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications: Table 1. Journal of Epidemiology and Community Health. https://doi.org/10.1136/jech.56.12.951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.